Acrux Limited (AU:ACR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Acrux Limited is set to host an Investor Webinar on December 17 to update shareholders and investors on the commercialisation of its Nitroglycerin 0.4% ointment. Acrux, a specialty pharma company, has a strong track record in developing topical pharmaceutical products and is seeking to expand its market presence through partnerships and new product developments.
For further insights into AU:ACR stock, check out TipRanks’ Stock Analysis page.
